公开(公告)号：US20230308835A1

公开(公告)日：2023-09-28

申请号：US17640291

申请日：2020-09-04

Applicant: NOVARTIS AG

Inventor： Sebastien IRIGARAY ,  Laurent KLEIN ,  Darko SKEGRO ,  Marco VILLANI ,  Karl WELZENBACH

IPC: H04W4/029 ,  H04W4/02

CPC classification number: H04W4/029 ,  H04W4/025

Abstract: A determination is made that a mobile device is associated with a reference activity of a user based on motion, orientation, rotational, magnetic field, and/or location data provided by sensors of the device. Activity data associated with the reference activity is obtained from the sensor-provided data. The activity data is recorded on the device for a configured period of time after which it is determined that the device is no longer performing the reference activity. The retained activity data for the reference activity is sent from the device to a network-based behavior analyzer when a network connection is available from the device. The network-based behavior analyzer derives user behaviors for the reference activity based on the activity data.

公开(公告)号：US20230265160A1

公开(公告)日：2023-08-24

申请号：US17640293

申请日：2020-09-04

Applicant: NOVARTIS AG

Inventor： Sebastien IRIGARAY ,  Laurent KLEIN ,  Darko SKEGRO ,  Marco VILLANI ,  Karl WELZENBACH

IPC: C07K14/705 ,  C07K14/765 ,  A61P29/00

CPC classification number: C07K14/70546 ,  A61P29/00 ,  C07K14/765 ,  C07K2319/21

Abstract: The present invention relates to fusion proteins suitable for use as a medicament or research tool. Therapeutic uses of the fusion proteins may include the prevention or treatment of acute or chronic inflammatory and immune system-driven organ and micro-vascular disorders, for example, acute kidney injury, acute myocardial infarction, acute respiratory distress or chronic obstructive pulmonary disease fibrosis and other organ injuries resulting from tissue trauma and acute and chronic injury.

公开(公告)号：US20230220048A1

公开(公告)日：2023-07-13

申请号：US17640295

申请日：2020-09-04

Applicant: NOVARTIS AG

Inventor： Sebastien IRIGARAY ,  Laurent KLEIN ,  Darko SKEGRO ,  Marco VILLANI ,  Karl WELZENBACH

IPC: C07K14/765 ,  C07K14/485 ,  C07K14/705

CPC classification number: C07K14/765 ,  C07K14/485 ,  C07K14/7056 ,  C07K2319/30 ,  C07K2319/31 ,  A61K38/00

Abstract: The present invention relates to fusion proteins suitable for use as a medicament or research tool. Therapeutic uses of the fusion proteins may include the prevention or treatment of acute or chronic inflammatory and immune system-driven organ and micro-vascular disorders, for example, acute kidney injury, acute myocardial infarction, acute respiratory distress or chronic obstructive pulmonary disease fibrosis and other organ injuries resulting from tissue trauma and acute and chronic injury.